These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3488189)

  • 21. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J; Santos L; Ramirez M;
    Rev Port Pneumol; 2006; 12(1):9-30. PubMed ID: 16572254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branhamella catarrhalis respiratory infections in The Netherlands.
    Maesen FP; Davies BI
    Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
    J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
    Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C
    J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal.
    Melo-Cristino J; Fernandes ML; Serrano N;
    Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.
    Hu F; Zhu D; Wang F; Morrissey I; Wang J; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i33-43. PubMed ID: 27048581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic modification of aminoglycoside antibiotics by Branhamella catarrhalis carrying an R factor.
    Robledano L; Rivera MJ; Otal I; Gómez-Lus R
    Drugs Exp Clin Res; 1987; 13(3):137-43. PubMed ID: 3304917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
    Le Faou A; Rio A
    Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
    Ninane G; Joly J; Kraytman M; Piot P
    Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045
    [No Abstract]   [Full Text] [Related]  

  • 38. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
    Nicotra B; Rivera M; Luman JI; Wallace RJ
    Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains.
    Nagatake T
    Tohoku J Exp Med; 1985 Sep; 147(1):1-13. PubMed ID: 3000026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.